Published in Medicine (Baltimore) on November 01, 2015
Pulmonary Artery Occlusion and Mediastinal Fibrosis in a Patient on Dopamine Agonist Treatment for Hyperprolactinemia. Front Pharmacol (2017) 0.75
Medical Management of Pulmonary Hypertension with Unclear and/or Multifactorial Mechanisms (Group 5): Is There a Role for Pulmonary Arterial Hypertension Medications? Curr Hypertens Rep (2017) 0.75
ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med (2002) 31.79
Sarcoidosis. N Engl J Med (2007) 14.92
Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol (2013) 8.29
Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol (2013) 4.89
Fibrotic disorders associated with methysergide therapy for headache. N Engl J Med (1966) 3.80
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation (2005) 2.98
Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol (2013) 2.07
An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J (2014) 2.01
Mediastinal fibrosis complicating histoplasmosis. Medicine (Baltimore) (1988) 1.91
The radiographic findings of fibrosing mediastinitis. Chest (1994) 1.82
Treatment of pulmonary artery compression due to fibrous mediastinitis with endovascular stent placement. Chest (2001) 1.50
Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis. Medicine (Baltimore) (1972) 1.44
A large urban outbreak of histoplasmosis: clinical features. Ann Intern Med (1981) 1.24
Fibrosing mediastinitis: clinical presentation, therapeutic outcomes, and adaptive immune response. Medicine (Baltimore) (2011) 1.21
Sclerosing mediastinitis: a report on 18 cases. Thorax (1995) 1.11
Targeting B lymphocytes in progressive fibrosing mediastinitis. Am J Respir Crit Care Med (2014) 1.04
Percutaneous pulmonary artery and vein stenting: a novel treatment for mediastinal fibrosis. Am J Respir Crit Care Med (2001) 1.03
Mediastinal fibrosis is associated with human leukocyte antigen-A2. Chest (2000) 1.03
Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension. Eur Heart J (2010) 1.01
Sarcoidosis complicated with major pulmonary artery obstruction and stenosis. Intern Med (2012) 0.98
The multiple roentgen manifestations of sclerosing mediastinitis. Johns Hopkins Med J (1979) 0.93
Mediastinal fibrosis. Semin Respir Infect (2001) 0.90
Mediastinal fibrosis and superior vena cava syndrome. Arch Bronconeumol (2013) 0.89
Pulmonary vascular occlusion and fibrosing mediastinitis. Chest (1986) 0.87
Imaging of granulomatous fibrosing mediastinitis. AJR Am J Roentgenol (2012) 0.85
Bronchial stenosis and sclerosing mediastinitis: an uncommon complication of external thoracic radiotherapy. Eur Respir J (1998) 0.85
Bilateral pleural effusion due to mediastinal fibrosis induced by radiotherapy. Chest (1993) 0.85
Fibrosing mediastinitis: an unusual cause of pulmonary symptoms. J Gen Intern Med (2013) 0.82
Computed tomography and the idiopathic form of proliferative fibrosing mediastinitis. J Thorac Imaging (2007) 0.79
Idiopathic pulmonary hilar fibrosis: an unusual cause of pulmonary hypertension. Mayo Clin Proc (1993) 0.77
[Mediastinal fibrosis combined with Behçet's disease. Three case reports]. Rev Med Interne (2000) 0.77
Sclerosing mediastinitis. Presumed to be due to primary aspergillosis. N Y State J Med (1977) 0.77
Short report: a case of fibrosing mediastinitis caused by Wuchereria bancrofti. Am J Trop Med Hyg (1996) 0.77
[Fibrosing mediastinitis diagnosed by thoracoscopic biopsy]. Kyobu Geka (2013) 0.76
[Superior vena cava syndrome due to tuberculous mediastinal fibrosis. Report of two cases (author's transl)]. Med Clin (Barc) (1979) 0.76
Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med (2005) 9.27
A hemodynamic study of pulmonary hypertension in sickle cell disease. N Engl J Med (2011) 7.21
Treatment of pulmonary arterial hypertension. N Engl J Med (2004) 6.88
2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J (2014) 6.32
Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med (2006) 6.06
Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation (2010) 5.87
Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med (2013) 5.60
Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med (2013) 4.98
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol (2002) 4.79
Inhaled iloprost for severe pulmonary hypertension. N Engl J Med (2002) 3.90
Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol (2009) 3.75
Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol (2004) 3.63
Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J (2004) 3.51
Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med (2014) 3.50
Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum (2005) 3.44
Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial. Ann Intern Med (2008) 3.13
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation (2005) 2.98
Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol (2004) 2.93
Pulmonary arterial hypertension in patients treated by dasatinib. Circulation (2012) 2.87
Role for interleukin-6 in COPD-related pulmonary hypertension. Chest (2009) 2.73
Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. Circulation (2013) 2.64
Chronic thromboembolic pulmonary hypertension. Circulation (2006) 2.58
Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol (2009) 2.57
Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension. Am J Respir Crit Care Med (2012) 2.52
Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med (2008) 2.48
New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. Chest (2004) 2.47
Is pulmonary arterial hypertension really a late complication of systemic sclerosis? Chest (2009) 2.40
Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension. Eur Heart J (2006) 2.34
Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension. Eur Respir J (2012) 2.32
Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension. Hum Mutat (2006) 2.30
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. N Engl J Med (2015) 2.23
CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am J Respir Crit Care Med (2002) 2.15
C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med (2011) 2.12
Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation. Am J Respir Crit Care Med (2008) 2.09
T-helper 17 cell polarization in pulmonary arterial hypertension. Chest (2015) 2.09
Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era. Am J Respir Crit Care Med (2007) 2.03
Retrospective institutional study of 31 patients treated for pulmonary artery sarcoma. Eur J Cardiothorac Surg (2012) 1.97
Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Circ Res (2004) 1.92
Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension. Eur Respir J (2013) 1.92
Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation (2011) 1.92
Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology (2005) 1.88
Severe asthma in adults: what are the important questions? J Allergy Clin Immunol (2007) 1.85
Ambrisentan therapy for pulmonary arterial hypertension. J Am Coll Cardiol (2005) 1.82
Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia. Circulation (2006) 1.79
Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol (2002) 1.77
Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis. Arthritis Rheum (2013) 1.73
Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease. Chest (2004) 1.72
Portopulmonary hypertension: survival and prognostic factors. Am J Respir Crit Care Med (2008) 1.71
Sternal resection and reconstruction for primary malignant tumors. Ann Thorac Surg (2004) 1.71
Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up study. Chest (2003) 1.71
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol (2008) 1.69
BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension. Hum Mutat (2006) 1.69